Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.
about
A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LBLactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of ClostridiGenotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases.Attenuation of Colitis by Lactobacillus casei BL23 Is Dependent on the Dairy Delivery Matrix.Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strainThe impact of early gut microbiota modulation on the risk of child disease: alert to accuracy in probiotic studies.VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function.Influence of Technological Treatments on the Functionality of Bifidobacterium lactis INL1, a Breast Milk-Derived Probiotic.Proteomes of Lactobacillus delbrueckii subsp. bulgaricus LBB.B5 Incubated in Milk at Optimal and Low Temperatures.Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.Future access and improvement of industrial lactic acid bacteria cultures.Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study.
P2860
Q26771884-C690DECB-D17B-47A8-8787-F4C539DDF2BDQ27012496-47DC28A1-9DDB-499F-820E-D939CD82F516Q28822302-A803C064-9894-46AA-8A7D-366FAA5947D1Q35688499-335BD3B4-18FC-4850-8CCC-74BEF6B05620Q36140994-B975AAFB-7C95-4E4F-8C58-24B4B2FC23CDQ36632722-5CB2756D-FD20-4CA0-B528-38C84B5230F4Q38331558-4877125B-9ADB-4509-BAF2-80DA89A29CCEQ38720190-637A00AC-D560-4482-B809-D68191D12F08Q40053883-6439EAA1-91CB-44B7-8DD9-AF83C7FE91D7Q41689745-83395A9C-48BF-477D-B031-C23FAD5D2529Q44802067-D162DAFD-6F37-4A58-AA61-798134EE4FABQ47120273-313E7CA1-CCF0-414E-B8D3-4D71F9D6954FQ53794169-AA3DF6EF-7EA3-4C3E-A34D-21A25D4EC3DE
P2860
Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effects of genetic, processing ...... cacy and safety of probiotics.
@en
type
label
Effects of genetic, processing ...... cacy and safety of probiotics.
@en
prefLabel
Effects of genetic, processing ...... cacy and safety of probiotics.
@en
P2093
P2860
P50
P356
P1476
Effects of genetic, processing ...... cacy and safety of probiotics.
@en
P2093
Arthur C Ouwehand
Charles Franz
Eric Johansen
Greg Leyer
James T Heimbach
Julia Tennilä
Maria L Marco
Mary Ellen Sanders
P2860
P356
10.1111/NYAS.12363
P407
P577
2014-02-01T00:00:00Z